Parathyroid Hormone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05829 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | amenorrhea (disease) | KG + DL |
| 4 | Raynaud disease | KG + DL |
| 5 | non-syndromic esophageal malformation | KG + DL |
| 6 | migraine with or without aura, susceptibility to | KG + DL |
| 7 | esophageal disease | KG + DL |
| 8 | atrophoderma vermiculata | KG + DL |
| 9 | ulerythema ophryogenesis | KG + DL |
| 10 | erectile dysfunction (disease) | KG + DL |
| 11 | esophageal ulcer | KG + DL |
| 12 | sciatic neuropathy | KG + DL |
| 13 | open-angle glaucoma | KG + DL |
| 14 | primary hereditary glaucoma | KG + DL |
| 15 | homozygous familial hypercholesterolemia | KG + DL |
| 16 | postural orthostatic tachycardia syndrome | KG + DL |
| 17 | lesion of sciatic nerve | KG + DL |
| 18 | malignant catarrh | KG + DL |
| 19 | infectious bovine rhinotracheitis | KG + DL |
| 20 | antithrombin deficiency type 2 | KG + DL |
| 21 | cytomegalovirus infection | KG + DL |
| 22 | esotropia | KG + DL |
| 23 | heparin cofactor 2 deficiency | KG + DL |
| 24 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 25 | pulmonary hypertension | KG + DL |
| 26 | duodenal ulcer (disease) | KG + DL |
| 27 | hypoalphalipoproteinemia | KG + DL |
| 28 | kyphoscoliotic heart disease | KG + DL |
| 29 | Prinzmetal angina | KG + DL |
| 30 | duodenogastric reflux | KG + DL |
| 31 | duodenal obstruction | KG + DL |
| 32 | ventricular tachycardia | KG + DL |
| 33 | thrombophilia | KG + DL |
| 34 | obsolete bundle branch block | KG + DL |
| 35 | cauda equina syndrome | KG + DL |
| 36 | monogenic obesity | KG + DL |
| 37 | severe nonproliferative diabetic retinopathy | KG + DL |
| 38 | adrenal gland hyperfunction | KG + DL |
| 39 | peripheral vascular disease | KG + DL |
| 40 | peripheral arterial disease | KG + DL |
| 41 | hyperthyroidism | KG + DL |
| 42 | periodic paralysis with transient compartment-like syndrome | KG + DL |
| 43 | seborrheic dermatitis | KG + DL |
| 44 | keratosis pilaris | KG + DL |
| 45 | catecholaminergic polymorphic ventricular tachycardia | KG + DL |
| 46 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 47 | obsolete susceptibility to ischemic stroke | KG + DL |
| 48 | glaucoma 1, open angle | KG + DL |
| 49 | arrhythmogenic right ventricular cardiomyopathy | KG + DL |
| 50 | glaucoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.